Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marina V, Pleten"'
Autor:
Andriy V. Trailin, Marina V. Pleten, Tetyana I. Ostapenko, Nadiia F. Iefimenko, Olexandr S. Nykonenko
Publikováno v:
BMC Research Notes, Vol 10, Iss 1, Pp 1-10 (2017)
Abstract Background Predictive factors for the rate of decline in kidney allograft function beyond the first post-transplant year have not been thoroughly studied. We aimed to determine whether a single measurement of serum and urinary interleukin 2,
Externí odkaz:
https://doaj.org/article/bffec272c5504c739b0ebbd8c56a95ff
Publikováno v:
Cell and Organ Transplantology. 3:13-19
The most investigations of the biomarkers of renal allograft dysfunction (RAD) are limited by early post-operational period and are aimed at diagnosis of acute rejection of renal transplant. This work has aimed to establish additional characteristics
Publikováno v:
BMC Research Notes
BMC Research Notes, Vol 10, Iss 1, Pp 1-10 (2017)
BMC Research Notes, Vol 10, Iss 1, Pp 1-10 (2017)
Background Predictive factors for the rate of decline in kidney allograft function beyond the first post-transplant year have not been thoroughly studied. We aimed to determine whether a single measurement of serum and urinary interleukin 2, interleu
Autor:
Andriy V, Trailin, Marina V, Pleten, Tatiana I, Ostapenko, Nadia F, Iefimenko, Olexander S, Nikonenko
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 15(3)
Scant information is available on factors for predicting the rate of decline in kidney allograft function beyond 1 year posttransplant.We investigated whether urinary enzymes (alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase
Autor:
Trailin Av, Tatiana I. Ostapenko, Olexander S. Nikonenko, Nadiia F. Iefimenko, Marina V. Pleten
Publikováno v:
Disease Markers
Disease Markers, Vol 2015 (2015)
Disease Markers, Vol 2015 (2015)
Background.Identification of patients at risk for kidney allograft (KAG) failure beyond the first posttransplant year is an unmet need. We aimed to determine whether serum beta-2-microglobulin (β2MG) in the late posttransplant period could predict a